207 related articles for article (PubMed ID: 32294049)
21. Solid variant of primary effusion lymphoma in successfully treated HIV infection: a case report.
Mylona E; Baraboutis IG; Georgiou O; Rondogianni D; Lekakis LJ; Papastamopoulos V; Apostolidis I; Skoutelis AT
Int J STD AIDS; 2008 Aug; 19(8):570-2. PubMed ID: 18663051
[TBL] [Abstract][Full Text] [Related]
22. Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin's lymphoma.
Lurain K; Ramaswami R; Mangusan R; Widell A; Ekwede I; George J; Ambinder R; Cheever M; Gulley JL; Goncalves PH; Wang HW; Uldrick TS; Yarchoan R
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33608378
[TBL] [Abstract][Full Text] [Related]
23. Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.
Gopal S; Patel MR; Yanik EL; Cole SR; Achenbach CJ; Napravnik S; Burkholder GA; Reid EG; Rodriguez B; Deeks SG; Mayer KH; Moore RD; Kitahata MM; Eron JJ; Richards KL
J Natl Cancer Inst; 2013 Aug; 105(16):1221-9. PubMed ID: 23892362
[TBL] [Abstract][Full Text] [Related]
24. Acquired immunodeficiency syndrome-related lymphomas: future directions.
Porcu P; Caligiuri MA
Semin Oncol; 2000 Aug; 27(4):454-62. PubMed ID: 10950372
[TBL] [Abstract][Full Text] [Related]
25. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.
Oksenhendler E; Boulanger E; Galicier L; Du MQ; Dupin N; Diss TC; Hamoudi R; Daniel MT; Agbalika F; Boshoff C; Clauvel JP; Isaacson PG; Meignin V
Blood; 2002 Apr; 99(7):2331-6. PubMed ID: 11895764
[TBL] [Abstract][Full Text] [Related]
26. Viral and cellular cytokines as therapeutic targets in AIDS-related lymphoproliferative disorders.
Aoki Y; Tosato G
Curr Drug Targets Cardiovasc Haematol Disord; 2003 Mar; 3(1):81-96. PubMed ID: 12769647
[TBL] [Abstract][Full Text] [Related]
27. Raising awareness of non-Hodgkin lymphoma in HIV-infected adolescents: report of 2 cases in the HAART era.
Zangari P; Santilli V; Cotugno N; Manno E; Palumbo G; Lombardi A; De Vito R; Tchidjou H; Baldassari S; Ariganello P; Pontrelli G; De Florio F; Palma P; Bernardi S
J Pediatr Hematol Oncol; 2013 Apr; 35(3):e134-7. PubMed ID: 23426000
[TBL] [Abstract][Full Text] [Related]
28. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma.
Deloose ST; Smit LA; Pals FT; Kersten MJ; van Noesel CJ; Pals ST
Leukemia; 2005 May; 19(5):851-5. PubMed ID: 15744337
[TBL] [Abstract][Full Text] [Related]
29. Malignant lymphomas (ML) and HIV infection in Tanzania.
Mwakigonja AR; Kaaya EE; Mgaya EM
J Exp Clin Cancer Res; 2008 Jun; 27(1):9. PubMed ID: 18577266
[TBL] [Abstract][Full Text] [Related]
30. HIV Type 1 replication in cerebrospinal fluid of patients with AIDS-related non-Hodgkin's lymphoma receiving chemotherapy and antiretroviral therapy.
Giancola ML; Uccella I; Alba L; Lorenzini P; Soldani F; Capobianchi M; Ruco L; Perno CF; Antinori A
AIDS Res Hum Retroviruses; 2003 Dec; 19(12):1091-5. PubMed ID: 14709245
[TBL] [Abstract][Full Text] [Related]
31. Non-Hodgkin's lymphoma as a rare manifestation of immune reconstitution disease in HIV-1 positive patients.
Knysz B; Kuliszkiewicz-Janus M; Jeleń M; Podlasin R; Gładysz A
Postepy Hig Med Dosw (Online); 2006; 60():547-51. PubMed ID: 17060896
[TBL] [Abstract][Full Text] [Related]
32. GI-lymphomas in immunosuppressed patients (organ transplantation; HIV).
Heise W
Best Pract Res Clin Gastroenterol; 2010 Feb; 24(1):57-69. PubMed ID: 20206109
[TBL] [Abstract][Full Text] [Related]
33. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas.
Carbone A; Gloghini A; Larocca LM; Capello D; Pierconti F; Canzonieri V; Tirelli U; Dalla-Favera R; Gaidano G
Blood; 2001 Feb; 97(3):744-51. PubMed ID: 11157493
[TBL] [Abstract][Full Text] [Related]
34. Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era.
Cingolani A; Fratino L; Scoppettuolo G; Antinori A
J Neurovirol; 2005; 11 Suppl 3():38-44. PubMed ID: 16540454
[TBL] [Abstract][Full Text] [Related]
35. Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study.
Gibson TM; Morton LM; Shiels MS; Clarke CA; Engels EA
AIDS; 2014 Sep; 28(15):2313-8. PubMed ID: 25111081
[TBL] [Abstract][Full Text] [Related]
36. HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscape.
Carroll V; Garzino-Demo A
Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26121984
[TBL] [Abstract][Full Text] [Related]
37. Managing HIV and Hodgkin lymphoma in the twenty-first century.
Aries J; Montoto S
Curr Hematol Malig Rep; 2014 Sep; 9(3):227-32. PubMed ID: 24906351
[TBL] [Abstract][Full Text] [Related]
38. Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).
Chow KU; Mitrou PS; Geduldig K; Helm EB; Hoelzer D; Brodt HR
Leuk Lymphoma; 2001 Mar; 41(1-2):105-16. PubMed ID: 11342362
[TBL] [Abstract][Full Text] [Related]
39. Clinical management of HIV-associated hematologic malignancies.
Wang CC; Kaplan LD
Expert Rev Hematol; 2016; 9(4):361-76. PubMed ID: 26652941
[TBL] [Abstract][Full Text] [Related]
40. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.
Castillo JJ; Furman M; Beltrán BE; Bibas M; Bower M; Chen W; Díez-Martín JL; Liu JJ; Miranda RN; Montoto S; Nanaji NM; Navarro JT; Seegmiller AC; Vose JM
Cancer; 2012 Nov; 118(21):5270-7. PubMed ID: 22510767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
